Treating osteoporosis requires a long term commitment. When appropriately risk stratified, treatment is effective. But as in any chronic disease, treating thin bones is a long term proposition. Evidence continues to emerge that helps to guide both the duration of therapy and f/u status checks. The link below reminds us that after bisphosphonate therapy ends (usually 5 years), an immediate post treatment dexa scan helps to predict fracture risk better than blood tests and/or ongoing dexa’s.